Migraine associated with jaw bone disease Anjali Nimesh Nimesh27 Sept 2017 9:30 AM ISTIn a study, researchers at the University of São Paulo's Ribeirão Preto School of Medicine (FMRP-USP), in Brazil, have found that the more frequent...
Vagus Nerve Stimulation device approved by FDA for prevention of Chronic Migraine Dr. Kamal Kant Kohli Kohli30 Jan 2018 7:25 PM ISTIn a multicenter, double-blind, sham-controlled pilot study PRESTO conducted to evaluate the feasibility, safety, and tolerability of noninvasive...
New guideline for pharmacological management of migraine Medha Baranwal Baranwal9 Jun 2018 7:01 PM ISTThe Scottish Intercollegiate Guidelines Network (SIGN) has issued new guidelines for pharmacological management of adults with acute migraine, and...
Levetiracetam effective in prophylaxis of Episodic Migraine Vinay Singh singh13 Jun 2018 8:28 PM ISTThe antiepileptic drug levetiracetam appears to be safe and effective prophylactic treatment option for an episodic migraine, according to a...
BOTOX an effective option for Prophylaxis of Migraine in children Dr. Kamal Kant Kohli Kohli28 July 2018 8:10 PM ISTIn a study, Dr.Shah S and associates have found that BOTOX is an effective option for Prophylactic Treatment of a Paediatric Migraine. This is the...
All about BOTOX : Dr Deepali Bhardwaj Hina Zahid19 Dec 2018 1:33 PM ISTBotox is clinically used to treat certain muscular conditions, and cosmetically to remove wrinkles by temporarily paralyzing muscles. BOTOX Cosmetic...
Riboflavin supplementation reduces headache severity in migraine patients Medha Baranwal Baranwal4 Aug 2019 8:20 PM ISTDelhi: Supplementation with riboflavin may decrease the severity of headache in migraine patients deficient in vitamin B3 and other micronutrients,...
Intravenous eptinezumab may prevent migraine for 3 months confirms phase 3 trial Medha Baranwal Baranwal14 Aug 2019 8:27 PM ISTUSA: Intravenous eptinezumab, an anti‐CGRP (calcitonin gene-related peptide) monoclonal antibody, showed efficacy for the prevention of chronic...
Migraine: Ajovy effective in treatment resistant patients, results from HALO and FOCUS trial Medha Baranwal Baranwal17 Sept 2019 7:25 PM ISTUSA: Fremanezumab (Ajovy), indicated for the preventive treatment of migraine in adults, received FDA approval in 2018. It functions by targeting...
